s6y
Company name or ticker
Search
AN2 Therapeutics, Inc.
ARS
Annual report to security holders
Filed
Wednesday, April 22, 2026
Period
Dec 31, 2025
Accession number
0001193125-26-170328
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header